SCHEMBL19079750

SCHEMBL19079750

CSc1nc2sc3c(c2c(=O)n1C1CC1)CCCC3

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.73
▸ NPSR1 Q6W5P4 2/20 0.63
▸ MAPT P10636 4/20 0.57
▸ LMNA P02545 2/20 0.57
▸ HPGD P15428 3/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ KDM4E B2RXH2 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ GLA P06280 1/20 0.52
▸ POLB P06746 2/20 0.51
▸ ATM Q13315 1/20 0.51
▸ GRK2 P25098 1/20 0.51
▸ CTDSP1 Q9GZU7 1/20 0.51
▸ ELANE P08246 1/20 0.50
▸ GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1101960 0.84 ALDH1A1 (1.00) ALDH1A1NPSR1MAPTLMNAHPGD
SCHEMBL1101914 0.79 POLB (0.76) ALDH1A1NPSR1MAPTLMNACYP1A2
SCHEMBL4732712 0.78 ALDH1A1 (0.68) ALDH1A1NPSR1MAPTLMNAHPGD
SCHEMBL19079736 0.76 PDE4D (0.68) ALDH1A1NPSR1MAPTHPGDKDM4E
SCHEMBL13962176 0.75 ALDH1A1 (0.68) ALDH1A1NPSR1MAPTLMNAHPGD
SCHEMBL19079823 0.75 CREBBP (0.78) ALDH1A1NPSR1MAPTLMNAHPGD
SCHEMBL19079693 0.75 PDE4D (0.57) ALDH1A1NPSR1MAPTHPGDKDM4E
SCHEMBL13407753 0.75 MAPT (0.78) ALDH1A1NPSR1MAPTLMNAKDM4E
SCHEMBL1101912 0.75 ALDH1A1 (0.66) ALDH1A1NPSR1MAPTLMNATSHR
SCHEMBL19079754 0.74 PDE4D (0.71) ALDH1A1NPSR1MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase VANDERBILT UNIVERSITY (US) 2019-06-25 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase PDE4A, PDE4B, PDE7A ALDH1A1 1503/4885NPSR1 3243/4885MAPT 4761/4885
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A ALDH1A1 1503/4885NPSR1 3243/4885MAPT 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback